ENTITY
Kelun Biotech

Kelun Biotech (1885133D CH)

39
Analysis
Health Care • China
Kelun Biotech operates biotechnology businesses. The Company develops and provides biological drugs, chemical raw materials, chemical preparations, and other products. Kelun Biotech also operates import and export businesses.
more
•16 Jul 2023 08:08

ECM Weekly (16th July 2023) - LG Energy, Socionext, Plus Alpha, Syngenta, Cinema XXI, Genda, Fadu

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
712 Views
Share
bullish•Kelun Biotech
•12 Jul 2023 09:25

Pre-IPO Kelun Biotech (PHIP Updates) - Some Points Worth the Attention

Currently, Kelun-Biotech's market value has already been higher than that of Keymed. Considering Keymed has complete R&D team within the company,...

Logo
859 Views
Share
bullish•Kelun Biotech
•10 Jul 2023 15:03

Kelun-Biotech (科伦博泰) IPO Trading: Lukewarm Demand but Peers Have Done Well Recently

Kelun Biotech will start trading on July 11th. We provide an update of the IPO before its debut. We think the deal attracted lukewarm demand but...

Logo
566 Views
Share
•02 Jul 2023 07:18

ECM Weekly (2nd July 2023) - Tryt, J&T Express, Redox, Kelun, 4Paradigm, SIA, M&A Research, Walsin

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
606 Views
Share
bearish•Kelun Biotech
•28 Jun 2023 17:29

Kelun-Biotech (科伦博泰) IPO: Fairly Valued at Best

Kelun-biotech, a China-based biopharmaceutical company, launched a deal to raise up to US$200m via a Hong Kong listing. We provide quick thoughts...

Logo
742 Views
Share
x